We are live on ! Find out more
1WA

180 Wealth Advisors Portfolio holdings

AUM $997M Turnover 12.62%
1-Year Est. Return 47.84%
This Fund
S&P 500
This Quarter Est. Return
+22.12%
1 Year Est. Return
+47.84%
3 Year Est. Return
+135.74%
5 Year Est. Return
+171.8%
10 Year Est. Return
–
AUM
$997M
AUM Growth
+$118M
Cap. Flow
+$8.08M
Cap. Flow %
0.81%
Top 10 Hldgs %
22.96%
Holding
515
New
43
Increased
193
Reduced
240
Closed
22
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
3.3 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
3.8 years
Top 10 Avg Time Held Equity only
3.3 years
Top 20 Avg Time Held Equity only
3.7 years

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$3.97M
2
INTC icon
Intel
INTC
+$3.32M
3
MDT icon
Medtronic
MDT
+$2.41M
4
GS icon
Goldman Sachs
GS
+$1.08M
5
NVDA icon
NVIDIA
NVDA
+$1M

Sector Composition

Rank Sector Weight
1 Technology 30.63%
2 Miscellaneous 28.57%
3 Healthcare 8.36%
4 Consumer Discretionary 6.88%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BA icon
76
Boeing
BA
$150B
$3.32M 0.33%
15,325
-168
-1% -$37.4K
2017 Q4
34 quarters
REMX icon
77
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.56B
$3.3M 0.33%
37,272
-2,142
-5% -$208K
2021 Q4
18 quarters
CRWV icon
78
CoreWeave
CRWV
$33.9B
$3.3M 0.33%
33,137
+466
+1% +$50.3K
2025 Q4
2 quarters
BLK icon
79
Blackrock
BLK
$176B
$3.29M 0.33%
3,427
-18
-0.5% -$18.6K
2025 Q1
5 quarters
RKLB icon
80
Rocket Lab Corp
RKLB
$32.5B
$3.24M 0.33%
31,904
-1,874
-6% -$187K
2025 Q3
3 quarters
JNJ icon
81
Johnson & Johnson
JNJ
$616B
$3.24M 0.32%
12,751
+538
+4% +$125K
2017 Q4
34 quarters
PEP icon
82
PepsiCo
PEP
$179B
$3.09M 0.31%
22,792
+544
+2% +$81.3K
2018 Q3
31 quarters
OGN icon
83
Organon & Co
OGN
$3.61B
$3.07M 0.31%
226,383
-1,588
-0.7% -$19K
2023 Q3
11 quarters
HQL icon
84
abrdn Life Sciences Investors
HQL
$510M
$3.06M 0.31%
152,829
+3,271
+2% +$57.8K
2019 Q1
29 quarters
VTI icon
85
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$3.03M 0.3%
8,187
-780
-9% -$279K
2017 Q4
34 quarters
LLY icon
86
Eli Lilly
LLY
$1.12T
$3.03M 0.3%
2,524
-44
-2% -$45K
2020 Q1
25 quarters
COPX icon
87
Global X Copper Miners ETF NEW
COPX
$6.87B
$2.93M 0.29%
38,051
+8,354
+28% +$695K
2022 Q4
14 quarters
CVX icon
88
Chevron
CVX
$441B
$2.91M 0.29%
17,584
-816
-4% -$152K
2017 Q4
34 quarters
CMG icon
89
Chipotle Mexican Grill
CMG
$37.8B
$2.9M 0.29%
85,161
+18,630
+28% +$609K
2023 Q4
10 quarters
PANW icon
90
Palo Alto Networks
PANW
$280B
$2.85M 0.29%
8,365
-303
-3% -$69.4K
2022 Q4
14 quarters
ANET icon
91
Arista Networks
ANET
$223B
$2.84M 0.29%
16,733
+842
+5% +$132K
2025 Q1
5 quarters
IEFA icon
92
iShares Core MSCI EAFE ETF
IEFA
$190B
$2.82M 0.28%
29,220
-3,062
-9% -$294K
2017 Q4
34 quarters
BG icon
93
Bunge Global
BG
$20.4B
$2.8M 0.28%
+26,274
New +$3.23M
2026 Q2
0 quarters
SYM icon
94
Symbotic
SYM
$5.04B
$2.77M 0.28%
61,717
+2,116
+4% +$108K
2024 Q3
7 quarters
RTX icon
95
RTX Corp
RTX
$261B
$2.73M 0.27%
14,406
-31
-0.2% -$5.68K
2023 Q4
10 quarters
LAD icon
96
Lithia Motors
LAD
$6.49B
$2.65M 0.27%
9,116
+328
+4% +$93.2K
2025 Q1
5 quarters
VOE icon
97
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$2.65M 0.27%
13,392
-607
-4% -$117K
2019 Q3
27 quarters
VTWO icon
98
Vanguard Russell 2000 ETF
VTWO
$16.1B
$2.63M 0.26%
21,623
-133
-0.6% -$15.1K
2020 Q1
25 quarters
ORCL icon
99
Oracle
ORCL
$389B
$2.55M 0.26%
17,416
+1,410
+9% +$256K
2017 Q4
34 quarters
GS icon
100
Goldman Sachs
GS
$257B
$2.54M 0.25%
2,511
-1,105
-31% -$1.08M
2020 Q3
23 quarters

Similar funds

180 Wealth Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, 180 Wealth Advisors held 515 positions worth $997M, up 13% from $880M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

180 Wealth Advisors's Q2 2026 filing shows 43 new, 193 increased, 240 reduced and 22 closed positions. Its largest new stake was AstraZeneca: 20,498 shares worth $3.89M. The largest sale was Target, an estimated $3.97M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

  • 180 Wealth Advisors's largest Q2 2026 buy was AstraZeneca: 20,498 shares worth $3.89M.
  • 180 Wealth Advisors added most to MannKind Corp in Q2 2026, an estimated $2.17M increase.
  • 180 Wealth Advisors's biggest Q2 2026 reduction was Intel, cutting an estimated $3.32M.
  • 180 Wealth Advisors fully exited Target in Q2 2026, selling an estimated $3.97M.
  • 180 Wealth Advisors's ten largest holdings make up 23% of its $997M portfolio in Q2 2026.
  • 180 Wealth Advisors opened 43 new positions and closed 22 in Q2 2026.
  • 180 Wealth Advisors's portfolio value rose 13% quarter-over-quarter to $997M.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.